Alec van Gelder/LinkedIn
Dec 5, 2025, 06:04
Alec van Gelder: Expanding Global Support for People with Blood Disorder
Alec van Gelder, Vice President of Corporate Affairs, Rare Disease at Novo Nordisk, shared on LinkedIn:
“Congratulations to the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation as you expand your reach to support even more people living with haemophilia, sickle cell disease, and thalassaemia. Wishing the NNHF Council and team continued success as you amplify your impact and shape a brighter future for patients and communities living with blood disorders worldwide.”
Stay informed with Hemostasis Today.
-
Apr 21, 2026, 21:07Tareq Abadl: Not Every Low Platelet Count Is True – Check the Smear First
-
Apr 21, 2026, 21:05Beverley Hunt: Honored to Receive the Lifetime Achievement Award at BSH 2026
-
Apr 21, 2026, 21:03Toong Youttananukorn: Proud to Support Data That Drives Action at WFH 2026
-
Apr 21, 2026, 20:48Ney Carter Borges: Endothelial Senescence as a Central Driver of Adipose Dysfunction in Heart Failure and Type 2 Diabetes
-
Apr 21, 2026, 20:29Can Stem Cell-Delivered Platelets Fight Drug-Resistant Bacteria?- RPTH Journal
-
Apr 21, 2026, 18:51WHO Expert Lorenzo Moja Discusses How Essential Medicines Policy Expands Access to Treatment – WFH
-
Apr 21, 2026, 18:35Ana Pedrero Gil: New ASH–ISTH 2026 Guidelines Focus on Preventing VTE in Children
-
Apr 21, 2026, 17:36Sip Wijchers: Is It Time to Use Ultrasound for Every AF Ablation Access?
-
Apr 21, 2026, 16:32Sarah Walbolt։ Have You Ever Wondered What Actually Happens to Your Donated Blood?